---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-100341"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T22:51:06.553984+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma reports exercise of pre-funded warrants for 2.08M shares of common stock

## Summary
- Investor exercised Pre-Funded Warrants to purchase 2,084,509 shares of common stock on July 24, 2025.
- Exercise price paid in cash was $208.45 in aggregate, representing a nominal per-share price.
- Warrants were issued under the PIPE Offering initially disclosed on July 17, 2025, with exercise price of $3.4199 per warrant.
- Shares were issued in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D exemption.

## SEC filing metadata
- accession: 0000950170-25-100341
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000095017025100341/0000950170-25-100341-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000095017025100341/meip-20250724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-100341
- JSON: https://secwatch.observer/filing/0000950170-25-100341.json
- Plain text: https://secwatch.observer/filing/0000950170-25-100341.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.